About the group
The group focuses on clinical and translational studies in both early and advanced breast cancer. We have extensive research activity with a number of ongoing researcher-initiated studies.
Aim of research
The aim is to contribute to developing new therapeutic strategies for both early breast cancer and metastatic breast cancer. This includes a focus on different treatment modalities in breast cancer, their effects and side effects, as well as clinically relevant diagnostic improvements.
In addition, participation in international multi-center studies is important, both to increase cooperation with international groups and researchers, and to ensure experience with new drugs in early phases.
Individualized Breast Cancer Treatment
Our ongoing and future research activities have focus on how to further individualize breast cancer treatment, aiming at higher efficacy by better refinement of subgroups sensitive to a certain treatment, identification of new therapeutic targets and/or improved knowledge of optimal treatment of established therapeutic targets.
Also, studies for better selection of patients who do not need systemic adjuvant treatment, as well as those who need alternative treatment strategies because of insufficiency of standard treatment approaches, have high priority.
Consequently, we focus on translational research, which includes an important and close collaboration with several research groups.
